Amgen
FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer
May 17, 2024Medical Communications Amgen, FDA, Oncology, lung cancer
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult …
Amgen opens new biomanufacturing facility in Ohio, US
February 27, 2024Manufacturing and Production Amgen, Biomanufacturing, Manufacturing Facility, Ohio, Pharmacy, US
Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. This will be the latest …
AstraZeneca and Amgen asthma drug shows positive results in Phase III trial
May 13, 2021Amgen, AstraZeneca, asthma, asthma treatment, pharma, pharma news, severe asthma
AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority across all primary and secondary …
Amgen stomach cancer drug awarded Breakthrough Therapy Designation
April 21, 2021Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news
Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …
Amgen to acquire Five Prime Therapeutics for approximately $1.9bn
March 5, 2021Medical Communications Amgen, Cancer, five prime
Amgen has announced it will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of …
Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal
October 9, 2020Medical Communications Amgen, cytokines, heart failure, pharma
New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …
Amgen poised to cut 172 positions across US, including California HQ
November 19, 2019Manufacturing and Production Amgen, US, pharma
As revealed in correspondence with the California Employment Development Department, Amgen plans to axe 172 staff positions across the US, …
Sandoz scores FDA approval for Neulasta biosimilar Ziextenzo to treat febrile neutropenia infection
November 6, 2019Research and Development, Sales and Marketing Amgen, FDA, Neulasta, Sandoz, Ziextenzo, pharma
The FDA has authorised the availability of Sandoz’s Ziextenzo (pegfilgrastim-bmez), a biosimilar version of Amgen’s Neulasta, it has emerged. The …
Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region
November 1, 2019Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma
Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …
Amgen’s Kyprolis + Darzalex combo shows progression-free survival benefit in multiple myeloma
September 16, 2019Research and Development, Sales and Marketing Amgen, Kyrpolis, darzalex, multiple myeloma, pharma
Amgen has revealed new Phase 3 data for the combination of Kyprolis (carfilzomib) and Darzalex (daratumumab) in addition to the …
Top Ten most popular articles on Pharmafile.com this week!
July 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma
On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …
Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse
July 12, 2019Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research
Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …
US Judge blocks Trump administration law requiring pharma to include prices in TV ads
July 9, 2019Manufacturing and Production Amgen, Eli Lilly, MSD, TV ads, Trump, USA, court, pharma
A judge has blocked the Trump administration from enacting a law that would require pharmaceutical companies to include the prices …
NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population
June 19, 2019Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma
Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …
Drugmakers sue Trump over prices in TV ads
June 17, 2019Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma
Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …
